TY - JOUR AU - Goldstone, A. H. AU - Richards, S. M. AU - Lazarus, H. M. AU - Tallman, M. S. AU - Buck, G. AU - Fielding, A. K. PY - 2008 DA - 2008// TI - In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the international ALL trial (MRC UKALL XII/ECOG E2993) JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-10-116582 DO - 10.1182/blood-2007-10-116582 ID - Goldstone2008 ER - TY - JOUR AU - Cornelissen, J. J. AU - Holt, B. AU - Verhoef, G. E. AU - Veer, M. B. AU - Oers, M. H. AU - Schouten, H. C. PY - 2009 DA - 2009// TI - Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-07-168625 DO - 10.1182/blood-2008-07-168625 ID - Cornelissen2009 ER - TY - JOUR AU - Aljurf, M. AU - Weisdorf, D. AU - Alfraih, F. AU - Szer, J. AU - Muller, C. AU - Confer, D. PY - 2019 DA - 2019// TI - Worldwide network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries JO - Bone Marrow Transplant VL - 54 UR - https://doi.org/10.1038/s41409-019-0476-6 DO - 10.1038/s41409-019-0476-6 ID - Aljurf2019 ER - TY - JOUR AU - Wang, Y. AU - Liu, Q. F. AU - Xu, L. P. AU - Liu, K. Y. AU - Zhang, X. H. AU - Ma, X. PY - 2016 DA - 2016// TI - Haploidentical versus matched-sibling transplant in adults with Philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III randomized study JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-2335 DO - 10.1158/1078-0432.CCR-15-2335 ID - Wang2016 ER - TY - JOUR AU - Han, L. J. AU - Wang, Y. AU - Fan, Z. P. AU - Huang, F. AU - Zhou, J. AU - Fu, Y. W. PY - 2017 DA - 2017// TI - Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission JO - Br J Haematol VL - 179 UR - https://doi.org/10.1111/bjh.14854 DO - 10.1111/bjh.14854 ID - Han2017 ER - TY - JOUR AU - Shem-Tov, N. AU - Peczynski, C. AU - Labopin, M. AU - Itala-Remes, M. AU - Blaise, D. AU - Labussiere-Wallet, H. PY - 2020 DA - 2020// TI - Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT JO - Leukemia VL - 34 UR - https://doi.org/10.1038/s41375-019-0544-3 DO - 10.1038/s41375-019-0544-3 ID - Shem-Tov2020 ER - TY - JOUR AU - Giebel, S. AU - Marks, D. I. AU - Boissel, N. AU - Baron, F. AU - Chiaretti, S. AU - Ciceri, F. PY - 2019 DA - 2019// TI - Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT) JO - Bone Marrow Transplant VL - 54 UR - https://doi.org/10.1038/s41409-018-0373-4 DO - 10.1038/s41409-018-0373-4 ID - Giebel2019 ER - TY - JOUR AU - Yan, C. H. AU - Jiang, Q. AU - Wang, J. AU - Xu, L. P. AU - Liu, D. H. AU - Jiang, H. PY - 2014 DA - 2014// TI - Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remission JO - Biol Blood Marrow Transplant VL - 20 UR - https://doi.org/10.1016/j.bbmt.2014.04.011 DO - 10.1016/j.bbmt.2014.04.011 ID - Yan2014 ER - TY - JOUR AU - Bashey, A. AU - Zhang, M. -. J. AU - McCurdy, S. R. AU - St. Martin, A. AU - Argall, T. AU - Anasetti, C. PY - 2017 DA - 2017// TI - Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell–replete haploidentical donor transplantation using post-transplant cyclophosphamide JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2017.72.8428 DO - 10.1200/JCO.2017.72.8428 ID - Bashey2017 ER - TY - JOUR AU - Sestili, S. AU - Labopin, M. AU - Ruggeri, A. AU - Velardi, A. AU - Ciceri, F. AU - Maertens, J. PY - 2018 DA - 2018// TI - T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: a study from the acute leukemia working Party of the European Society of blood and marrow transplantation (EBMT) JO - Cancer VL - 124 UR - https://doi.org/10.1002/cncr.31310 DO - 10.1002/cncr.31310 ID - Sestili2018 ER - TY - JOUR AU - Siegel, S. E. AU - Stock, W. AU - Johnson, R. H. AU - Advani, A. AU - Muffly, L. AU - Douer, D. PY - 2018 DA - 2018// TI - Pediatric-inspired treatment regimens for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: a review JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2017.5305 DO - 10.1001/jamaoncol.2017.5305 ID - Siegel2018 ER - TY - JOUR AU - Rytting, M. E. AU - Jabbour, E. J. AU - Jorgensen, J. L. AU - Ravandi, F. AU - Franklin, A. R. AU - Kadia, T. M. PY - 2016 DA - 2016// TI - Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Munster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen JO - Am J Hematol VL - 91 UR - https://doi.org/10.1002/ajh.24419 DO - 10.1002/ajh.24419 ID - Rytting2016 ER - TY - STD TI - NCCN guideline: Acute lymphoblastic leukemia. Version2.2019; http://www.nccn.org. UR - http://www.nccn.org ID - ref13 ER - TY - STD TI - NCCN guideline: Pediatric acute lymphoblastic leukemia. Version1.2020; http://www.nccn.org. UR - http://www.nccn.org ID - ref14 ER - TY - JOUR AU - Curran, E. AU - Stock, W. PY - 2019 DA - 2019// TI - Taking a “BiTE out of ALL”: blinatumomab approval for MRD-positive ALL JO - Blood VL - 133 UR - https://doi.org/10.1182/blood-2018-12-852376 DO - 10.1182/blood-2018-12-852376 ID - Curran2019 ER -